U.S. markets open in 6 hours 2 minutes

Regen BioPharma, Inc. (RGBP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0427+0.0011 (+2.64%)
At close: 3:59PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
9/30/2020
9/30/2019
9/30/2018
9/30/2017
Total Revenue
2,015
110
110
100
110
Operating Expense
232.06
319.317
866.785
1,526
2,621
Operating Income
1,783
-209.317
-756.785
-1,426
-2,511
Net Non Operating Interest Income Expense
-409.507
-942.933
-1,701
-1,553
-589.206
Other Income Expense
-3,675
4,567
-165.438
-1,736
-2,739
Pretax Income
-2,302
3,414
-2,623
-4,715
-5,839
Net Income Common Stockholders
-2,542
2,732
-2,623
-4,715
-5,839
Diluted NI Available to Com Stockholders
-2,542
2,732
-2,623
-4,715
-5,839
Basic EPS
-
0.00
-0.00
-0.03
-0.04
Diluted EPS
-
0.00
-0.00
-0.03
-0.04
Basic Average Shares
-
1,409,847
2,071,156
152,091
141,426
Diluted Average Shares
-
1,409,847
2,071,156
152,091
141,426
Rent Expense Supplemental
10
18.548
60
60
60
Total Expenses
232.06
319.317
866.785
1,526
2,621
Net Income from Continuing & Discontinued Operation
-2,542
2,732
-2,623
-4,715
-5,839
Normalized Income
1,133
-602.1334
-2,456
-3,249
-3,046
Interest Income
-
0
1.302
10.234
1.858
Interest Expense
409.603
942.933
1,702
1,563
591.064
Net Interest Income
-409.507
-942.933
-1,701
-1,553
-589.206
EBIT
-1,892
4,357
-920.921
-3,152
-5,248
EBITDA
-1,892
-
-
-
-
Net Income from Continuing Operation Net Minority Interest
-2,542
2,732
-2,623
-4,715
-5,839
Total Unusual Items Excluding Goodwill
-3,675
4,567
-167.169
-1,466
-2,793
Total Unusual Items
-3,675
4,567
-167.169
-1,466
-2,793
Normalized EBITDA
1,783
-209.317
-753.752
-1,686
-2,455
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
1,233
0
0
0